BAC
Bank of America Corporation
BAC has lower modeled downside risk, despite its lower overall score.
SNEX
StoneX Group Inc.
SNEX has a slight edge over BAC overall, supported by stronger fundamentals.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
SNEX Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| N/A | |
| N/A |
SNEX's revenue and profitability are currently strong. Free cash flow and net leverage aren't meaningful measures for financial services companies like SNEX.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC has the edge over SNEX in the historical PE scenario, which offers more potential upside but is not a forecast.
SNEX PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 8x | $33.61 | -41% |
| Fair | 10x | $43.51 | -24% |
| Forward | 13x | $57.11 | — |
| Current | 14x | $57.11 | — |
| Expensive | 15x | $64.87 | +14% |
Historical ranges are pointers, not guarantees.
SNEX's PE is in its expensive range at 14x. If earnings grow as analysts expect, today's price would be 13x next year's earnings.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for BAC, with profitability improving.
SNEX Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for SNEX, with profitability improving.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC has the edge over SNEX on earnings, with stronger typical year-over-year growth.
SNEX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.42 | +5.6% |
| Q2 2026 | $4.19 | +61% |
| Q1 2026 | $3.73 | +42% |
| Q4 2025 | $2.98 | +20% |
| Q3 2025 | $2.62 | +11% |
| Q2 2025 | $2.61 | +22% |
| Q1 2025 | $2.62 | +18% |
| Q4 2024 | $2.48 | +17% |
| Q3 2024 | $2.36 | +6.8% |
SNEX's earnings per share have climbed steadily: $4.19 over the past year, up 61% from the year before, and higher year over year for eight quarters in a row.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC's revenue has grown year over year for 10 quarters in a row: $30B last quarter, up 6.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC has the edge over SNEX on profitability, with a higher operating margin.
SNEX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $719.7M | +47% |
| Q1 2026 | $829.1M | +70% |
| Q4 2025 | $724.4M | +47% |
| Q3 2025 | $585.1M | +29% |
| Q2 2025 | $488.3M | +4.2% |
| Q1 2025 | $487.3M | +15% |
| Q4 2024 | $492.1M | +17% |
| Q3 2024 | $454.8M | +13% |
SNEX has the edge over BAC on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 22% | +24 points |
| Q1 2026 | 27% | +29 points |
| Q4 2025 | 26% | +30 points |
| Q3 2025 | 19% | +21 points |
| Q2 2025 | -2.2% | +3.5 points |
| Q1 2025 | -1.8% | +1.3 points |
| Q4 2024 | -4.3% | -0.6 points |
| Q3 2024 | -2.1% | -21 points |
SNEX's operating margin was 22% last quarter, up 24 points from the same quarter a year ago.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC has the edge over SNEX on cash flow, with more consistent year-over-year improvement.
SNEX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$1.2B | -183% |
| Q1 2026 | $2.8B | +$2.9B |
| Q4 2025 | -$1.3B | -$785.5M |
| Q3 2025 | $3.5B | +1895% |
| Q2 2025 | $1.5B | +$2.1B |
| Q1 2025 | -$169.8M | -122% |
| Q4 2024 | -$491.4M | -452% |
| Q3 2024 | $175.9M | -51% |
SNEX's free cash flow was $3.8B over the past year, about four times what it generated the year before. Free cash flow isn't a meaningful measure for financial services companies like SNEX.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over SNEX on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
SNEX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.9% | +2.3M shares |
| 1 year | +11% | +12.1M shares |
| 3 years | +19% | +19.9M shares |
| 5 years | +24% | +24M shares |
| Available history | +29% | +28.2M shares |
SNEX has 124M diluted shares, up 11% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2022 | — |
| Q3 2021 | $8.6M |
| Q2 2021 | $3.1M |
| Q1 2021 | — |
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | $7.1M |
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
SNEX Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -2.0x | Net Cash |
| Q1 2026 | -2.6x | Net Cash |
| Q4 2025 | -3.1x | Net Cash |
| Q3 2025 | -6.1x | Net Cash |
| Q2 2025 | -71.1x | Net Cash |
| Q2 2024 | -14.8x | Net Cash |
| Q1 2024 | -5.5x | Net Cash |
| Q4 2023 | -1.5x | Net Cash |
SNEX has the edge over BAC on leverage, with a lower net debt burden relative to earnings.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
SNEX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.2 | Neutral |
| Stochastic | 11.8 | Oversold |
SNEX's weekly RSI is 41 (neutral) and its Stochastic is 12 (oversold).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC has the edge over SNEX on valuation relative to its sector.
SNEX PE vs Financial Services Sector
| Metric | SNEX | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 4.8% above |
| PE % | 76 | 63 | 13 pts above |
SNEX is trading at 14x earnings, in line with the Financial Services sector's median of 13x.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
SNEX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $59.0 | 3.2% below |
| 20 week MA | $66.4 | 14% below |
| 50 week MA | $62.7 | 8.8% below |
| 100 week MA | $50.4 | 13% above |
| 200 week MA | $35.6 | 60% above |
SNEX has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.
SNEX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.59 | $11.2 | +17% |
| 2021 | $11.2 | $12.1 | +7.7% |
| 2022 | $12.1 | $19.1 | +58% |
| 2023 | $19.1 | $21.9 | +15% |
| 2024 | $21.9 | $29.4 | +34% |
| 2025 | $29.4 | $44.5 | +52% |
| 2026 YTD | $44.5 | $57.1 | +28% |
SNEX has the edge over BAC on returns for 2026, with the stronger performance.